ONK Therapeutics

Description

ONK Therapeutics develops ready-made natural killer cell therapies. These engineered treatments are intended for blood cancers and solid tumor oncology applications.

Related

• Iovance Biotherapeutics ($IOVA)Develops and manufactures tumor infiltrating lymphocyte therapies that use a patient’s immune cells, serving people with cancer and…
• THERAPANACEABuilds AI-driven oncology software and platforms for clinical teams and cancer centers to support segmentation, planning, and adaptive…
• Artiva Biotherapeutics ($ARTV)Develops off-the-shelf, non-genetically modified natural killer cell therapies for deep B-cell depletion, aiming to help patients with…
• ArsenalBioDevelops in vivo T cell therapies and reprogrammed CAR T approaches for chronic diseases, including cancer and autoimmunity, with focus on…
• TareBioDevelops vaccines intended for cancer and infectious diseases, addressing needs in oncology and infection prevention or treatment for…
• BetaGlue TherapeuticsDevelops a localized radiotherapeutic platform delivering precise intratumoral radiation for durable local control; used for unresectable…
• AerogenAerogen makes nebuliser systems that deliver aerosol medications.
• HAYA TherapeuticsBuilds RNA-guided therapies that reprogram disease-driving cell states; used to reverse cell states and restore health in therapeutic…
• Boundless Bio ($BOLD)Develops ecDNA-directed cancer therapies that target vulnerabilities in cancer cells for patients with intractable oncogene-amplified…
• BioInvent International ABBioInvent discovers and develops antibody-based immuno-oncology therapeutics; its tools and services support clinical trials, drug…
• Intelligent Therapeutics, Inc.Engineers antibodies and antibody-like molecules for treating solid tumors and rare autoimmune diseases, with pipeline work in companion…
• Faron Pharmaceuticals Ltd.Develops immunotherapies that leverage patients' immune systems for cancer treatment, serving clinical researchers and healthcare providers…